IRIS

Pharmacokinetic assessment of a prolonged release oral formulation containing Diltiazem.HCl

FERRARI, FRANCA;ROSSI, SILVIA STEFANIA;BONFERONI, MARIA CRISTINA;CARAMELLA, CARLA MARCELLA;DE BERNARDI DI VALSERRA, MARIO;FELETTI, FAUSTO
1992-01-01
1992
Pharmacology & Toxicology includes all aspects of pharmacology, toxicology, and pharmaceutics. Of particular importance are cellular and molecular pharmacology, drug design and metabolism, mechanisms of drug action, drug delivery, natural products, xenobiotics, and clinical therapeutics. Toxicology coverage considers cellular and molecular effects of harmful substances, environmental toxicology, occupational exposure, and clinical toxicology. Drug bulletins, drug updates, and pharmaceutical newsletters are excluded as are resources on pharmaceutical engineering. Medicinal chemistry, or synthesis and chemical analysis of pharmaceuticals are placed in the Chemistry & Analysis category.
PHARMACOLOGICAL RESEARCH
sì
2-s2.0-44049118526
Esperti anonimi
Inglese
Internazionale
STAMPA
26 S 1
172
172
1
Pharmacokinetic; prolonged release; oral formulation; Diltiazem
no
info:eu-repo/semantics/article
266
none
6
1 Contributo su Rivista::1.5 Abstract in rivista
Ferrari, Franca; Rossi, SILVIA STEFANIA; Bonferoni, MARIA CRISTINA; Caramella, CARLA MARCELLA; DE BERNARDI DI VALSERRA, Mario; Feletti, Fausto...espandi
1.5 Abstract in rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11571/464746
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? ND
social impact